A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response

external-publication
infectious-diseases
antimicrobial-resistance
Authors

Okhuysen PC

Ramesh MS

Louie T

Kiknadze N

Torre-Cisneros J

de Oliveira CM

Van Steenkiste C

Stychneuskaya A

Garey KW

Garcia-Diaz J

Li J

Duperchy E

Chang BY

Sukbuntherng J

Montoya JG

Styles L

Clow F

James D

Dubberke ER

Wilcox M

Doi

10.1093/cid/ciad792